James R. Eshleman

1992–2024 年に発表

別表記
James R Eshleman
102
論文数
52,317
被引用数
73
h 指数
100
i10 指数

被引用数

James R. Eshleman の年別被引用数1985 年: 被引用 2 件1986 年: 被引用 1 件1987 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 11 件1996 年: 被引用 23 件1997 年: 被引用 33 件1998 年: 被引用 34 件1999 年: 被引用 59 件2000 年: 被引用 86 件2001 年: 被引用 114 件2002 年: 被引用 117 件2003 年: 被引用 109 件2004 年: 被引用 157 件2005 年: 被引用 139 件2006 年: 被引用 135 件2007 年: 被引用 144 件2008 年: 被引用 134 件2009 年: 被引用 222 件2010 年: 被引用 268 件2011 年: 被引用 358 件2012 年: 被引用 379 件2013 年: 被引用 408 件2014 年: 被引用 443 件2015 年: 被引用 510 件2016 年: 被引用 705 件2017 年: 被引用 865 件2018 年: 被引用 990 件2019 年: 被引用 2,499 件2020 年: 被引用 2,823 件2021 年: 被引用 2,604 件2022 年: 被引用 1,772 件2023 年: 被引用 1,240 件2024 年: 被引用 1,631 件2025 年: 被引用 758 件2026 年: 被引用 17 件1988〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,097 件、この内訳の 30.2%中国: 引用元論文 2,791 件、この内訳の 11.9%イギリス: 引用元論文 1,440 件、この内訳の 6.1%ドイツ: 引用元論文 1,259 件、この内訳の 5.4%イタリア: 引用元論文 1,147 件、この内訳の 4.9%日本: 引用元論文 989 件、この内訳の 4.2%フランス: 引用元論文 877 件、この内訳の 3.7%スペイン: 引用元論文 729 件、この内訳の 3.1%オランダ: 引用元論文 708 件、この内訳の 3%カナダ: 引用元論文 707 件、この内訳の 3%オーストラリア: 引用元論文 620 件、この内訳の 2.6%韓国: 引用元論文 468 件、この内訳の 2%
0%30.2%その他 19.9%

分野

  • Medicine65.4%
  • Biochemistry, Genetics and Molecular Biology27.7%
  • Immunology and Microbiology4%
  • Engineering0.7%
  • Neuroscience0.5%
  • Computer Science0.4%
  • その他1.3%

トピック

  • Cancer Immunotherapy and Biomarkers8.6%
  • Pancreatic and Hepatic Oncology Research7.7%
  • Cancer Genomics and Diagnostics7.4%
  • Genetic factors in colorectal cancer5.7%
  • Colorectal Cancer Treatments and Studies3%
  • Immunotherapy and Immune Responses2.7%
  • その他64.9%

共著者

全論文

検索で開く
  1. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Janis M. Taube, Robert A. Anders, James R. Eshleman, Bert Vogelstein, Luis A. Díaz - New England Journal of Medicine 2015 被引用: 9,441

  2. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shibin Zhou, Richard M. Goldberg, Deborah K. Armstrong, Katherine M. Bever, Amanda N. Fader, Janis M. Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, James R. Eshleman, Bert Vogelstein, Robert A. Anders, Luis A. Díaz - Science 2017 被引用: 6,766

  3. Genomic analyses identify molecular subtypes of pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Darrin F. Taylor, Kelly Quek, Alan J. Robertson, Lorena Pantano, Laura Mincarelli, Luis Navarro-Sánchez, Lisa Evers, Jianmin Wu, Mark Pinese, Mark J. Cowley, Marc D. Jones, Emily K. Colvin, Adnan M. Nagrial, Emily S. Humphrey, Lorraine A. Chantrill, Amanda Mawson, Jeremy L. Humphris, Angela Chou, Marina Pajic, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Lovell, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Kim Moran‐Jones, Nigel B. Jamieson, Janet Graham, Fraser R. Duthie, Karin A. Oien, Jane Hair, Robert Grützmann, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Borislav C. Rusev, Paola Capelli, Roberto Salvia, Giampaolo Tortora, Debabrata Mukhopadhyay, Gloria M. Petersen, Australian Pancreatic Cancer Genome Initiative, Donna M. Munzy, William E. Fisher, Saadia A. Karim, James R. Eshleman, Ralph H. Hruban, Christian Pilarsky, Jennifer P. Morton, Owen J. Sansom, Aldo Scarpa, Elizabeth A. Musgrove, Ulla‐Maja Bailey, Oliver Hofmann, Robert L. Sutherland, David A. Wheeler, Anthony J. Gill, Richard A. Gibbs, John V. Pearson ほか 3 名 - Nature 2016 被引用: 3,775

  4. Whole genomes redefine the mutational landscape of pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Felicity Newell, Barsha Poudel, Sarah Song, Darrin F. Taylor, Nick M. Waddell, Scott Wood, Qinying Xu, Jianmin Wu, Mark Pinese, Mark J. Cowley, Hong C. Lee, Marc D. Jones, Adnan Nagrial, Jeremy L. Humphris, Lorraine A. Chantrill, Venessa Chin, Angela Steinmann, Amanda Mawson, Emily S. Humphrey, Emily K. Colvin, Angela Chou, Christopher J. Scarlett, Andreia V. Pinho, Marc Giry-Laterrière, Ilse Rooman, Jaswinder S. Samra, James G. Kench, Jessica A. Pettitt, Neil D. Merrett, Christopher W. Toon, Krishna Epari, Nam Q. Nguyen, Andrew P. Barbour, Nikolajs Zeps, Nigel B. Jamieson, Janet Graham, Simone P. Niclou, Rolf Bjerkvig, Robert Grützmann, Daniela E. Aust, Ralph H. Hruban, Anirban Maitra, Christine A. Iacobuzio–Donahue, Christopher L. Wolfgang, Richard A. Morgan, Rita T. Lawlor, Vincenzo Corbo, Claudio Bassi, Massimo Falconi, Giuseppe Zamboni, Giampaolo Tortora, Margaret A. Tempero, Anthony J. Gill, James R. Eshleman, Christian Pilarsky, Aldo Scarpa, Elizabeth A. Musgrove, John V. Pearson, Andrew V. Biankin, Sean M. Grimmond - Nature 2015 被引用: 2,709

  5. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler - Science 2008 被引用: 4,055

  6. Distant metastasis occurs late during the genetic evolution of pancreatic cancer

    著者: , , , , , , , , , , , , , - Nature 2010 被引用: 2,543

  7. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

    著者: , , , , , , , , , , - 1998 被引用: 4,128

  8. CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Xanthe L. Metcalf, Nicola Waddell, John V. Pearson, Ann-Marie Patch, Katia Nones, Felicity Newell, Pamela Mukhopadhyay, Venkateswar Addala, Stephen H. Kazakoff, Oliver Holmes, Conrad Leonard, Scott Wood, Sean M. Grimmond, Oliver Hofmann, Angelika N. Christ, Timothy J. C. Bruxner, Jaswinder S. Samra, Nick Pavlakis, Hilda A. High, Ray Asghari, Neil D. Merrett, Darren Pavey, Amitabha Das, Peter H. Cosman, Kasim Ismail, Chelsie O’Connnor, Alina Stoita, David Williams, Allan Spigellman, Vincent Lam, Duncan McLeod, Judy Kirk, James G. Kench, Peter Grimison, Caroline Cooper, Charbel Sandroussi, Annabel Goodwin, R. Scott Mead, Katherine Tucker, Lesley Andrews, Michael Texler, Cindy Forest, Krishna Epari, Mo Ballal, David Fletcher, Sanjay Mukhedkar, Nikolajs Zeps, Maria Beilin, Kynan Feeney, Nan Q. Nguyen, Andrew Ruszkiewicz, Chris Worthley, John Chen, Mark E. Brooke‐Smith, Virginia Papangelis, Andrew D. Clouston, Andrew P. Barbour, Thomas J. O’Rourke, Jonathan W. Fawcett, Kellee Slater, Michael Hatzifotis, Peter Hodgkinson, Mehrdad Nikfarjam, James R. Eshleman, Ralph H. Hruban, Christopher L. Wolfgang, Rita T. Lawlor, Stefania Beghelli, Vincenzo Corbo, Maria Scardoni ほか 21 名 - Nature Communications 2019 被引用: 261

  9. Microsatellite Instability as a Biomarker for PD-1 Blockade

    著者: , , , - Clinical Cancer Research 2016 被引用: 984

  10. Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 被引用: 484

  11. Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in Mice

    著者: , , , , , , , , , , , - Gastroenterology 2019 被引用: 229

  12. Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 193

  13. DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 1,078

  14. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2011 被引用: 637

  15. A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wooil Kwon, Seung‐Mo Hong, Ki Byung Song, Song Cheol Kim, Niall Swan, Jean Murphy, Justin Geoghegan, William R. Brugge, Carlos Fernández‐del Castillo, Mari Mino–Kenudson, Richard D. Schulick, Barish H. Edil, Volkan Adsay, Jorge Paulino, Jeanin E. van Hooft, Shinichi Yachida, Satoshi Nara, Nobuyoshi Hiraoka, Kenji Yamao, Susuma Hijioka, Van der Merwe, Michael Goggins, Marcia Irene Canto, Nita Ahuja, Kenzo Hirose, Martin A. Makary, Matthew J. Weiss, John L. Cameron, Meredith E. Pittman, James R. Eshleman, Luis A. Díaz, Nickolas Papadopoulos, Kenneth W. Kinzler, Rachel Karchin, Ralph H. Hruban, Bert Vogelstein, Anne Marie Lennon - Gastroenterology 2015 被引用: 458

  16. Patient-derived Organoid Pharmacotyping is a Clinically Tractable Strategy for Precision Medicine in Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2020 被引用: 117

  17. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James B. Potash, Andrew D. Rhim, Alyssa Smith, Yuxuan Wang, Christopher L. Wolfgang, Laura D. Wood, Peter P. Zandi, Michael Goggins, Rachel Karchin, James R. Eshleman, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Ralph H. Hruban, Alison P. Klein - Cancer Discovery 2015 被引用: 366

  18. Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

    著者: , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2011 被引用: 773

  19. Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

    著者: , , , , , , , , , , , , , , , , - The Prostate 2021 被引用: 69

  20. Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , - The Oncologist 2020 被引用: 58

  21. Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Oncotarget 2018 被引用: 157

  22. Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

    著者: , , , , , , , , , , , , , , , , , , , - Science 2009 被引用: 819

  23. SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2009 被引用: 371

  24. Diagnostic Performance of a Tumor Marker Gene Test to Personalize Serum CA19–9 Reference Ranges

    著者: , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2023 被引用: 30